Sort
30,917 grants matching “tumor microenvironment”
Contribution of Epigenome to PRKCI-Driven High-Grade Serous Ovarian Cancer
$416,543Kunal Rai · University Of Tx Md Anderson Can Ctr · R21 · FY2021 · CA
Functional Activation of Low Affinity TILs
$416,524Jill E Slansky · University Of Colorado Denver · R01 · FY2021 · CA
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$416,514Ann Marie Pendergast · Duke University · R01 · FY2025 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$416,494Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2019 · CA
Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo
$416,491Caigang Zhu · University Of Kentucky · R01 · FY2023 · DE
New Bioreactor-based approach to stem cell/progenitor expansion for cell therapie
$416,456Stephen Samuel Navran · Synthecon, Inc. · R44 · FY2011 · HD
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
$416,339Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2019 · GM
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$416,323Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2024 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$416,290Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2025 · CA
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$416,279Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AI
Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations
$416,259Timothy N Phoenix · University Of Cincinnati · R01 · FY2022 · NS
Impact of TNF on Oncolytic Virotherapy
$416,256Eric Carter Bartee · University Of New Mexico Health Scis Ctr · R01 · FY2024 · CA
Targeting TREM2 to boost anti-cancer therapy
$416,242Marco Colonna · Washington University · R01 · FY2021 · CA
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology
$416,215Charles J Rosser · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Molecular Mechanisms of Cachexia in Lung Cancer
$416,213Carlo M Croce · Ohio State University · R01 · FY2019 · CA
Understanding PPARgamma signaling in melanoma brain metastasis
$416,077Qing Chen · Wistar Institute · R01 · FY2021 · CA
DNP-MRSI for the Detection of Latent, Treatment-Resistant Cellular Domains in HCC
$416,075Terence P Gade · University Of Pennsylvania · R21 · FY2022 · CA
Understanding PPARgamma signaling in melanoma brain metastasis
$416,068Qing Chen · Wistar Institute · R01 · FY2020 · CA
Role of breast cancer secreted miRNA in brain metastasis
$416,046Shizhen Emily Wang · University Of California, San Diego · R01 · FY2023 · CA
Boosting Oncolytic HSV Immunotherapy by Enabling Necroptosis
$416,040Hongyan Guo · Louisiana State Univ Hsc Shreveport · R21 · FY2025 · CA
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$415,924David Porter · University Of Pennsylvania · P01 · FY2021 · CA
Role of EGFR in signaling by receptors of intracellular nucleic acids
$415,847Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · CA
Role of EGFR in signaling by receptors of intracellular nucleic acids
$415,847Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · CA
Bioorthogonal probe development for highly parallel in vivo imaging
$415,830Ralph Weissleder · Massachusetts General Hospital · R33 · FY2025 · CA
Bioorthogonal probe development for highly parallel in vivo imaging
$415,830Ralph Weissleder · Massachusetts General Hospital · R33 · FY2023 · CA